JP2019512511A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512511A5
JP2019512511A5 JP2018549202A JP2018549202A JP2019512511A5 JP 2019512511 A5 JP2019512511 A5 JP 2019512511A5 JP 2018549202 A JP2018549202 A JP 2018549202A JP 2018549202 A JP2018549202 A JP 2018549202A JP 2019512511 A5 JP2019512511 A5 JP 2019512511A5
Authority
JP
Japan
Prior art keywords
alkyl
conjugate
pharmaceutically acceptable
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549202A
Other languages
English (en)
Japanese (ja)
Other versions
JP7027325B2 (ja
JP2019512511A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/022785 external-priority patent/WO2017161170A1/en
Publication of JP2019512511A publication Critical patent/JP2019512511A/ja
Publication of JP2019512511A5 publication Critical patent/JP2019512511A5/ja
Application granted granted Critical
Publication of JP7027325B2 publication Critical patent/JP7027325B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549202A 2016-03-16 2017-03-16 炭酸無水酵素ixを標的とする薬剤および方法 Expired - Fee Related JP7027325B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662309268P 2016-03-16 2016-03-16
US201662309264P 2016-03-16 2016-03-16
US62/309,264 2016-03-16
US62/309,268 2016-03-16
PCT/US2017/022785 WO2017161170A1 (en) 2016-03-16 2017-03-16 Carbonic anhydrase ix targeting agents and methods

Publications (3)

Publication Number Publication Date
JP2019512511A JP2019512511A (ja) 2019-05-16
JP2019512511A5 true JP2019512511A5 (cg-RX-API-DMAC7.html) 2020-04-23
JP7027325B2 JP7027325B2 (ja) 2022-03-01

Family

ID=59852046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549202A Expired - Fee Related JP7027325B2 (ja) 2016-03-16 2017-03-16 炭酸無水酵素ixを標的とする薬剤および方法

Country Status (6)

Country Link
US (2) US11925696B2 (cg-RX-API-DMAC7.html)
EP (1) EP3429575A4 (cg-RX-API-DMAC7.html)
JP (1) JP7027325B2 (cg-RX-API-DMAC7.html)
AU (1) AU2017234676A1 (cg-RX-API-DMAC7.html)
CA (1) CA3017214A1 (cg-RX-API-DMAC7.html)
WO (1) WO2017161170A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019515880A (ja) * 2016-03-16 2019-06-13 エンドサイト・インコーポレイテッドEndocyte, Inc. 炭酸無水酵素ix阻害剤抱合体およびその使用
EP3429575A4 (en) 2016-03-16 2019-10-23 Purdue Research Foundation AGAINST CARBOANHYDRASE-IX DRUGS AND METHODS
WO2020045638A1 (ja) * 2018-08-30 2020-03-05 日本メジフィジックス株式会社 放射性イミダゾチアジアゾール誘導体化合物
IL323877A (en) * 2023-05-02 2025-12-01 Rayzebio Inc Radiopharmaceutical compositions targeting carbonic anhydrase ix and uses thereof
CN120943769B (zh) * 2025-08-08 2026-05-29 浙江普罗亭健康科技有限公司 可应用于质谱流式检测的金属离子螯合结构及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2438008T3 (es) 2002-05-06 2014-01-15 Endocyte, Inc. Agentes de formación de imágenes dirigidos a vitaminas
KR20050109934A (ko) * 2003-01-31 2005-11-22 프로메가 코포레이션 관능기의 단백질로의 공유 테더링
WO2006076463A2 (en) * 2005-01-12 2006-07-20 Amgen Inc. Kinase-directed, activity-based probes
RU2470668C2 (ru) 2005-08-19 2012-12-27 Эндосайт, Инк. Конъюгаты лиганда с несколькими лекарственными средствами
US20090043099A1 (en) 2006-03-17 2009-02-12 The Burnham Institute Methods and compositions for derepression of IAP-inhibited caspase
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
BRPI0812970A2 (pt) 2007-06-25 2019-09-24 Endocyte Inc conjugados contendo espaçadores hidrofílicos
DK2187965T3 (da) 2007-08-17 2020-01-20 Purdue Research Foundation Psma-bindingsligand-linker-konjugater og fremgangsmåder til anvendelse
CA2711678A1 (en) * 2008-01-09 2009-07-16 Molecular Insight Pharmaceuticals, Inc. Inhibitors of carbonic anhydrase ix
US8940501B2 (en) * 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
CN101596433B (zh) 2009-07-15 2011-07-06 中国科学院工程热物理研究所 U形返料器的冷却式隔板
FR2951449B1 (fr) 2009-10-15 2011-11-25 Commissariat Energie Atomique Procede de fonctionnalisation de molecules biologiques
EP2519823B1 (en) * 2009-12-28 2022-05-18 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Composite probes and use thereof in super resolution methods
EP2533775A1 (en) 2010-02-12 2012-12-19 Universita' Degli Studi di Firenze Carbonic anhydrase inhibitors
JP5544239B2 (ja) 2010-07-29 2014-07-09 富士フイルム株式会社 重合性組成物
EP2707102B1 (en) * 2011-05-09 2019-11-13 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same
DK2766364T3 (da) 2011-08-17 2024-09-30 Merck & Cie Folatkonjugater af albumin-bindende enheder
US20140249315A1 (en) 2013-03-01 2014-09-04 Endocyte, Inc. Processes for preparing tubulysins
WO2015113760A1 (en) * 2014-01-28 2015-08-06 Tube Pharmaceuticals Gmbh Cytotoxic tubulysin compounds for conjugation
US9771380B2 (en) * 2014-06-09 2017-09-26 University Of Oregon Gold nanoparticles and methods of making and using gold nanoparticles
EP3429575A4 (en) 2016-03-16 2019-10-23 Purdue Research Foundation AGAINST CARBOANHYDRASE-IX DRUGS AND METHODS
JP2019515880A (ja) 2016-03-16 2019-06-13 エンドサイト・インコーポレイテッドEndocyte, Inc. 炭酸無水酵素ix阻害剤抱合体およびその使用
CA3019835A1 (en) * 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy

Similar Documents

Publication Publication Date Title
JP2016505586A5 (cg-RX-API-DMAC7.html)
JP2006515838A5 (cg-RX-API-DMAC7.html)
JP2019519491A5 (cg-RX-API-DMAC7.html)
JP2014531434A5 (cg-RX-API-DMAC7.html)
JP2019524883A5 (cg-RX-API-DMAC7.html)
JP2015522650A5 (cg-RX-API-DMAC7.html)
JP2004516314A5 (cg-RX-API-DMAC7.html)
JP2017511360A5 (cg-RX-API-DMAC7.html)
JP2021527638A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
JP2017511815A5 (cg-RX-API-DMAC7.html)
JP2006507265A5 (cg-RX-API-DMAC7.html)
JP2008510691A5 (cg-RX-API-DMAC7.html)
JP2017526726A5 (cg-RX-API-DMAC7.html)
JP2010523599A5 (cg-RX-API-DMAC7.html)
JP2011528654A5 (cg-RX-API-DMAC7.html)
JP2011251990A5 (cg-RX-API-DMAC7.html)
JP2017132814A5 (cg-RX-API-DMAC7.html)
JP2016523270A5 (cg-RX-API-DMAC7.html)
JP2018525405A5 (cg-RX-API-DMAC7.html)
JP2021526123A5 (cg-RX-API-DMAC7.html)
JP2013523652A5 (cg-RX-API-DMAC7.html)
RU2003137593A (ru) Соединения на основе пептидов для направленной доставки к рецепторам интегринов
JP2012504608A5 (cg-RX-API-DMAC7.html)
JP2008505157A5 (cg-RX-API-DMAC7.html)